Company Spotlight: Aerie Pharmaceuticals

Shares of Aerie Pharmaceuticals Inc. (AERI) are up nearly 44% year-to-date, well ahead of the iShares Nasdaq Biotechnology Index (ETF) (IBB), which has returned only 28% during the same period.

from RTT - Biotech http://ift.tt/2wB5Pt0
via IFTTT